Antoun C, Oto J, Morelli V, Hveem K, Braekkan S, Medina P
Int J Mol Sci. 2025; 26(5).
PMID: 40076809
PMC: 11899732.
DOI: 10.3390/ijms26052191.
Mardi A, Ghovahi A, Abbasvandi F, Amani D
Biochem Genet. 2025; .
PMID: 40064800
DOI: 10.1007/s10528-025-11057-8.
Jiang Y, Qi S, Zhang R, Zhao R, Fu Y, Fang Y
Front Oncol. 2025; 14:1483521.
PMID: 39935848
PMC: 11810725.
DOI: 10.3389/fonc.2024.1483521.
Gianno F, Miele E, Sabato C, Ferretti E, Minasi S, Buttarelli F
Biomedicines. 2025; 13(1).
PMID: 39857696
PMC: 11762140.
DOI: 10.3390/biomedicines13010112.
Khanmohammadi S, Masrour M, Fallahtafti P, Hasani F
Cancer Rep (Hoboken). 2025; 8(1):e70070.
PMID: 39854617
PMC: 11760998.
DOI: 10.1002/cnr2.70070.
Investigating the association of microRNA polymorphisms and lifestyle factors with the susceptibility to common gastrointestinal cancers in an Indian population- A case control study.
Walter C, Shankaran Z, Kontham S, Ramachandran K, Prakash N, Johnson T
Heliyon. 2025; 11(1):e41519.
PMID: 39850417
PMC: 11755044.
DOI: 10.1016/j.heliyon.2024.e41519.
Polymorphic Single-Nucleotide Variants in miRNA Genes and the Susceptibility to Colorectal Cancer: Combined Evaluation by Pairwise and Network Meta-Analysis, Thakkinstian's Algorithm and FPRP Criterium.
Liu Q, Archilla I, Lopez-Prades S, Torres F, Camps J, Cuatrecasas M
Cancer Med. 2025; 14(2):e70621.
PMID: 39840720
PMC: 11751872.
DOI: 10.1002/cam4.70621.
miR-224-5p Suppresses Non-Small Cell Lung Cancer via IL6ST-Mediated Regulation of the JAK2/STAT3 Pathway.
Tian J, He Y, Zhang Z, Zhu Y, Ren H, Zhang L
Thorac Cancer. 2025; 16(2):e15516.
PMID: 39840666
PMC: 11751714.
DOI: 10.1111/1759-7714.15516.
Advancements in gene therapies targeting mutant KRAS in cancers.
Wang Y, Bui T, Yang X, Hutvagner G, Deng W
Cancer Metastasis Rev. 2025; 44(1):24.
PMID: 39820726
PMC: 11748474.
DOI: 10.1007/s10555-025-10243-9.
Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research.
Sharma R, Yadav J, Bhat S, Musayev A, Myrzagulova S, Sharma D
Mol Neurobiol. 2025; .
PMID: 39804528
DOI: 10.1007/s12035-024-04680-w.
Unlocking the epigenetic code: new insights into triple-negative breast cancer.
Mahendran G, Shangaradas A, Romero-Moreno R, Wickramarachchige Dona N, Sarasija S, Perera S
Front Oncol. 2025; 14:1499950.
PMID: 39744000
PMC: 11688480.
DOI: 10.3389/fonc.2024.1499950.
Dr. Jekyll or Mr. Hyde: The multifaceted roles of miR-145-5p in human health and disease.
Rahman M, Ghorai S, Panda K, Santiago M, Aggarwal S, Wang T
Noncoding RNA Res. 2024; 11:22-37.
PMID: 39736851
PMC: 11683234.
DOI: 10.1016/j.ncrna.2024.11.001.
miR-198 targets : implications for oral squamous cell carcinoma pathogenesis.
Kaushik P, Mishra R, Gopal C, Kumar A
Front Oncol. 2024; 14:1485802.
PMID: 39697236
PMC: 11652479.
DOI: 10.3389/fonc.2024.1485802.
Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors.
Gabellone S, Vanni S, Fausti V, Miserocchi G, Liverani C, Spadazzi C
Heliyon. 2024; 10(23):e40596.
PMID: 39687122
PMC: 11647801.
DOI: 10.1016/j.heliyon.2024.e40596.
CircRNAs and miRNAs: Key Player Duo in Breast Cancer Dynamics and Biomarkers for Breast Cancer Early Detection and Prevention.
Maatouk N, Kurdi A, Marei S, Nasr R, Talhouk R
Int J Mol Sci. 2024; 25(23).
PMID: 39684767
PMC: 11641287.
DOI: 10.3390/ijms252313056.
Establishment and bioinformatics analysis of a four-miRNA prognostic signature for pleural mesothelioma.
Yang X, Lin Y, Dong B, Li B, Liu R, Wang X
J Cancer. 2024; 15(20):6505-6520.
PMID: 39668817
PMC: 11632982.
DOI: 10.7150/jca.101914.
MicroRNAs: where brilliance, perseverance, and ambition converged.
Drula R, Calin G
J Clin Invest. 2024; 135(2).
PMID: 39656547
PMC: 11735086.
DOI: 10.1172/JCI189625.
Deciphering the role of LOC124905135-related non-coding RNA cluster in human cancers: A comprehensive review.
Eftekhari Kenzerki M, Mohajeri Khorasani A, Zare I, Amirmahani F, Ghasemi Y, Hamblin M
Heliyon. 2024; 10(22):e39931.
PMID: 39641053
PMC: 11617737.
DOI: 10.1016/j.heliyon.2024.e39931.
MicroRNA regulator gene mutations in thyroid follicular nodular disease and thyroid cancer: does it all come down to timing?.
Condello V, Juhlin C
Eur Thyroid J. 2024; 13(6).
PMID: 39601261
PMC: 11737542.
DOI: 10.1530/ETJ-24-0298.
MicroRNAs as Promising Therapeutic Agents Against Prostate Cancer Resistant to Castration-Where Are We Now?.
Ferreira M, Morais M, Medeiros R, Teixeira A
Pharmaceutics. 2024; 16(11).
PMID: 39598472
PMC: 11597238.
DOI: 10.3390/pharmaceutics16111347.